Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2015 Oct 14;8(11):1272–1281. doi: 10.1016/j.jcmg.2015.06.016

Figure 4. Combined HsTn I and advanced coronary CTA assessment and ACS in the ROMICAT II trial.

Figure 4

Flow diagram depicts the improvement of ACS risk stratification using hsTn I at the time of ED presentation. Further improvement of the risk stratification can be achieved with advanced assessment of coronary CTA for high-risk plaque.